Impact of macrophages on neutrophils and endothelial cells in the kidney in hemolytic uremic syndrome induced by shiga toxin-producing E-coli
Impact of macrophages on neutrophils and endothelial cells in the kidney in hemolytic uremic syndrome induced by shiga toxin-producing E-coli
批准号:
446477718
负责人:
Professor Dr. Daniel Robert Engel
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Hemolytic uremic syndrome (HUS) caused by shiga-toxin (Stx) producing E.coli (STEC) is an incurable foodborne disease leading to severe health conditions, requiring expensive and life-quality reducing supportive care. After ingestion, STEC colonize the gut and Stx produced by these pathogens traverses into the circulation, damaging the microvasculature, particularly in the kidney. There is emerging evidence for a critical role of neutrophils during STEC-HUS, and increased abundance of these cells is associated with a poor clinical outcome. In a preliminary study we found activation and accumulation of neutrophils within the renal glomerulus in a mouse model of STEC-HUS. We also noted a dense renal periglomerular macrophage network, indicating a crosstalk between macrophages and neutrophils during STEC-HUS. Depletion of macrophages resulted in reduced weight loss and kidney injury in STEC-HUS, demonstrating a crucial role for renal macrophages in STEC-HUS. This proposal aims at elucidating 1. How macrophages respond to STEC, 2. The quality of modulation of the kidney microenvironment by macrophages, 3. The downstream effects of the macrophage-response with a particular focus on neutrophils and 4. Whether targeting the key molecules on macrophages and neutrophils ameliorates disease severity. These experiments unravel the cellular and molecular mechanisms orchestrating the immune response in STEC-HUS. Furthermore, we clarify whether targeting macrophages and their products or macrophage-dependent neutrophil recruitment might be therapeutical targets to cure STEC-HUS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Suppression of the innate anti-bacterial response in Chronic Lymphocytic Leukemia
-
批准号:314635618
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Professor Dr. Daniel Robert Engel
-
依托单位:
Regulation of neutrophil migration by tissue macrophages
-
批准号:320670639
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Professor Dr. Daniel Robert Engel
-
依托单位:
Ontogenese und Migrationsverhalten pathogenetisch relevanter dendritischer Zellen und T Zellen im postoperativen Ileus
-
批准号:211082498
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Professor Dr. Daniel Robert Engel
-
依托单位:
Regulierung der Immunsuppression durch CD163 bei Pyelonephritis und chronischer lymphatischer Leukämie
-
批准号:509468008
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Daniel Robert Engel
-
依托单位:
国内基金
海外基金
登录
查看更多内容
上皮祖细胞应答巨噬细胞分泌因子IL-1β参与炎症微环境下输卵管纤毛分化障碍的机制研究
-
批准号:82371691
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:张健
-
依托单位:
SENP1调控巨噬细胞极性参与老年心肌纤维化的作用及机制
-
批准号:82371584
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:薛松
-
依托单位:
LIPUS促进微环境巨噬细胞释放CCL2诱导尿道周围平滑肌祖细胞定植与分化的机制研究
-
批准号:82370780
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:夏术阶
-
依托单位:
RAI16负调控肿瘤相关巨噬细胞c/EBPβ-TGF-β1通路抑制结直肠癌的机制研究
-
批准号:32100629
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:丁翠玲
-
依托单位:
M1-Th17免疫微环境调控Notch通路抑制TBI后内源性NSCs分化成熟的机制研究
-
批准号:32070791
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:孙洪涛
-
依托单位:
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
-
批准号:81970721
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:陶凌
-
依托单位:
肿瘤微环境中M-CSF和核因子kB上调Fra-1促进巨噬细胞向M2d型转化的机制
-
批准号:81171975
-
项目类别:面上项目
-
资助金额:48.0万元
-
批准年份:2011
-
负责人:王悦
-
依托单位: